Trial Profile
Pharmacogenetic evaluation of oxicodone in patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 May 2012
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Cancer pain
- Focus Pharmacogenomic; Therapeutic Use
- 28 Jul 2011 New trial record